stars 1 stars 2 stars 3

About Texcell We are a specialized CRO supporting biologics, vaccines, medical devices, cell and gene therapies, and other complex biological products. Our core expertise includes viral safety, viral clearance, biosafety testing, custom cell culture, cell banking support, and bioassays. For more than 30 years, clients have trusted Texcell for scientific rigor, responsive partnership, and practical support when programs need clarity. We design studies, solve technical questions, assess product safety, and move development programs forward with confidence. Our services include: Viral safety and biosafety testing for biological products, cell banks, raw materials, and cell-derived products. Viral clearance studies for biologics, gene therapies, and other biopharmaceutical products, including investigational and regulatory-supporting study designs. Custom cell culture and cell banking support, including cell line expansion, research cell banking, conditioned medium production, virus production, and purification. Bioassays and analytical support, including in vitro and in vivo bioassays, immune response evaluation, qPCR-based detection, and related testing for preclinical and clinical programs. Clients come to Texcell for the science. They stay because of the partnership.

Texcell Questions

The Texcell annual revenue was $15.6 million in 2026.

Tara Crnkovich is the CEO of Texcell.

74 people are employed at Texcell.

The NAICS codes for Texcell are [54, 5417, 54171, 541, 541713].

The SIC codes for Texcell are [87, 873].

Top Texcell Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users